EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter evaluation of the proposed EUCAST antifungal susceptibility testing method



Multicenter evaluation of the proposed EUCAST antifungal susceptibility testing method



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 372



Background: The Subcommittee of AFST of The European Committee on Antibiotic Susceptibility Testing has proposed a standard AFST for yeasts. This AFST is based on the reference NCCLS M27-A procedure, but incorporates modifications (JCM 39:525-32, 2001). We have evaluated its intra and inter-laboratory reproducibility. Methods: Nine laboratories participated in the study. Common material lots were used to test 6 Candida strains (1 each C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, C. krusei, C. lusitaniae), and two QC strains (C. krusei ATCC6258 and C. parapsilosis ATCC22019). Triplicate testing on 3 separate days vs. flucytosine (5FC), fluconazole (FLZ), and itraconazole (ITZ) was performed in RPMI-2% glucose. Agreement (AGR, % of MICs within one 2X dilution of the mode) and intraclass correlation coefficient (ICC, maximum value of 1) are shown. Results: The intra-lab AGR was >97% and >94.5% after 24h and 48h of incubation, respectively, with ICCs of >0.98 and >0.97. Two strains exhibiting trailing effect showed AGR of <92% and ICCs of <0.90 at 48h. The inter-lab AGR among 7 labs was 93% and 87% after 24h and 48h, respectively with ICCs of 0.98 and 0.97. The lowest values of AGR and ICC were obtained for ITZ (<84% and <0.93 respectively). Conclusions: (1) The procedure EUCAST AFST is a reproducible within and between labs. (2) Strains with trailing growth show reduced agreement and ICCs at 48h.

(PDF 0-2 workdays service: $29.90)

Accession: 035349838

Download citation: RISBibTeXText



Related references

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clinical Microbiology and Infection 9(6): 467-474, 2003

Evaluation of a modified EUCAST fragmented-mycelium inoculum method for in vitro susceptibility testing of dermatophytes and the activity of novel antifungal agents. Antimicrobial Agents and ChemoTherapy 59(6): 3675-3682, 2016

Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin. Antimicrobial Agents and ChemoTherapy 60(8): 5088-5091, 2016

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. Journal of Clinical Microbiology 35(1): 139-143, 1997

Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clinical Microbiology and Infection 13(10): 1018-1022, 2007

Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. Journal of Clinical Microbiology 40(10): 3841-3844, 2002

Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species. Antimicrobial Agents and ChemoTherapy 46(11): 3644-3647, 2002

Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clinical Microbiology and Infection 11(6): 486-492, 2005

Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates. Journal of Medical Microbiology 55(Pt 12): 1693-1699, 2006

Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. Medical Mycology 44(Supplement 1): S319-S325, 2006

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents. Clinical Microbiology and Infection 22(6): 571.E1-4, 2016

Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. Journal of Clinical Microbiology 48(5): 1782-1786, 2010

Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus. Clinical Microbiology and Infection, 2016

Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study. Journal of Clinical Microbiology 52(5): 1582-1589, 2015